Heartburn drugs linked to kidney damage in 50 percent of

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
1,068
Heartburn drugs linked to kidney damage in 50 percent of patients with no warning signs

Isn't this great, a doctor give patients the drug rather than guide him to a better diet to correct his heartburn? Out entire medical system is sick and corrupt, IMO

http://www.naturalhealth365.com/heartburn-dru...-2250.html

NaturalHealth365) Heartburn drugs like, Prevacid, Nexium and Prilosec are being consumed by up to 50 percent of all Americans suffering from acid reflux – and with big pharma pushing these ‘remedies’ – it’s no wonder why these medications have become household names.
Currently, over 15 million Americans have prescriptions for these proton pump inhibitors (PPIs) – which are intended to ease symptoms of reflux and heartburn by relieving gastric acid – with millions more purchasing these medications over the counter. But disturbing new studies link prolonged use of these familiar remedies with kidney damage – which can develop seemingly “out of the blue,” with no warning signs or symptoms.
Major warning about heartburn drugs: The problems can develop “silently”
In a five-year study of 125,000 patients published in Kidney International, researchers at Washington University School of Medicine in St. Louis found that more than half of the cases of chronic kidney damage and end-stage renal damage occurred in people without any previous record of kidney problems. According to senior study author Dr. Ziyad Al-Aly, assistant professor of medicine at Washington University School of Medicine, the study showed that kidney problems in patients taking PPIs can develop silently and gradually over time, eroding kidney function and leading to long-term kidney damage or even renal failure.
End-stage renal disease is the failure of kidneys to remove waste from the body, necessitating either dialysis or a kidney transplant.
Dr. Al-Aly warned that doctors must pay careful attention to kidney function in patients that use PPIs – which include lansoprazole, omeprazole and esomeprazole – even when there are no signs or symptoms of damage.
The study also evaluated 18,436 new users of another type of heartburn medication known as Histamine H2 receptor antagonists, or H2 blockers. While H2 blockers don’t work as well on heartburn, researchers found that these drugs are less likely to cause kidney problems.
Additional studies confirm researchers’ disturbing findings
An earlier study published in Journal of the American Society of Nephrology also showed that long-term use of heartburn medications is associated with kidney damage, with PPI users 28 percent more likely to experience chronic kidney disease, and a shocking 96 percent more likely to develop kidney failure.
The longer the drugs were taken, the higher the risk. And, the daily dosage affects risk as well.
In a study published in JAMA Internal Medicine, the team found that twice-a-day users of PPIs tripled their risk over people who took a single daily dose.
The research team called for using PPIs only when “medically necessary,” and limiting the duration of the treatment as well.
Lead author Dr. Morgan Grams, assistant professor of epidemiology at Johns Hopkins University, pointed out that up to 70 percent of acid reflux prescriptions are handed out “inappropriately” – and he estimated that a full 25 percent of long-term users could stop taking the medication without suffering increased heartburn or acid reflux.
Of course, stemming the flow of prescribed PPIs will do nothing to reduce the number of people buying – and taking – these medications over the counter.
And, the damage from PPIs isn’t limited to the kidneys.
PPIs affect absorption of essential vitamins and minerals
PPIs interfere with the ability of the body to extract vitamin B12, an essential nutrient, from foods. Studies have shown that 75 percent of PPI users have been found to be deficient in vitamin B-12 – compared to 11 percent among the general non-using population.
PPIs can cause dramatic declines in blood magnesium levels – characterized by symptoms of fatigue, unsteadiness, numbness and tingling, seizures and heart arrhythmias.
As if that weren’t enough, PPIs can also lead to poor calcium absorption, raising the risk of bone fracture – especially in older patients.
In addition, PPI users are more likely to be obese and have high blood pressure. Use of PPIs is also associated with higher rates of pneumonia and C. difficile, a potentially dangerous bacterial infection.
And, finally, a German study showed that older adults who take proton pump inhibitors have a 44 percent increased chance of developing dementia.
Natural solutions exist for acid reflux
Many natural health experts point out that heartburn typically results from too little stomach acid, rather than too much – and that PPIs can actually worsen the problem.
You may be able to ease heartburn and acid reflux with simple dietary and lifestyle changes – such as avoiding fried, fatty and processed foods, eating smaller meals, chewing food well and avoiding smoking and excessive drinking. Eating healthy amounts of vegetables and high-quality organic unprocessed foods can help restore natural gastric balance, while consuming fermented foods – such as sauerkraut, miso soup and kimchi – can help eliminate the H. pylori bacterium that can contribute to reflux.
Natural, time-honored remedies for heartburn include unfiltered apple cider vinegar, baking soda, ginger root tea, chamomile tea and slippery elm.
Of course, you shouldn’t stop or substitute any prescribed medication without first discussing it with your healthcare provider.
The best advice on PPIs comes from Dr. Kenneth DeVault, president of the American College of Gastroenterology. “If you don’t need these medications, you shouldn’t take them,” advises DeVault.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 148

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 32

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 75

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

LifeWave's Generous Donation Fuels Ocean Cleanup Initiative

Updated Category News Views 251

LifeWave's Commitment to a Cleaner Ocean LifeWave, recognized as a leading wellness technology company, has made headlines by announcing an impressive donation of $100,000 to The Ocean Cleanup. This non-profit organization is tirelessly working to eliminate plastic waste from our oceans, a cause that resonates deeply with LifeWave's own mission of enhancing well-being....

Continue Reading
Solutions30 Partners with Atlante for EVC Stations Expansion

Updated Category News Views 146

Solutions30's partnership with Atlante rolled out in early 2024, aiming to kickstart the construction of 50 electric vehicle charging (EVC) stations across southern Spain and Catalonia. This collaboration marks a significant leap in their ongoing relationship that began back in 2023, signaling both companies’ commitment to bolstering electric vehicle infrastructure amid...

Continue Reading
Zenos Health Reveals Innovative Keynote Speakers for Wellness Summit

Updated Category News Views 243

Exciting Keynote Lineup at the Zenos Wellness Summit Zenos Health has recently unveiled an impressive lineup of keynote presentations for the inaugural Zenos Wellness Summit, scheduled to take place in Riyadh. This event emphasizes the company's commitment to advancing longevity science and collaborative innovation. Highlighting Renowned Speakers The summit will feature...

Continue Reading
LIM College Joins Forces with Japan Educational Foundation

Updated Category News Views 166

The Exciting Acquisition of LIM College by JEF LIM College is pleased to announce the completion of its acquisition by the Japan Educational Foundation (JEF), marking a significant milestone in the world of higher education, particularly in the fashion industry. Even with this change in ownership, LIM will maintain its independent operations in New York City, allowing it...

Continue Reading
Bitcoin Depot Gears Up for Growth with New Leadership Changes

Updated Category News Views 168

Bitcoin Depot's Leadership Transition Bitcoin Depot, a prominent player in the Bitcoin ATM sector, is embracing a fresh leadership approach aimed at expanding its operational capacity and strategic vision. The company's recent announcement highlights the appointment of Scott Buchanan as the new Chief Executive Officer, effective from January 1, 2026. This significant...

Continue Reading